Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:PHR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumePHRPhreesia$22.23-2.3%$26.10$17.07▼$32.76$1.34B0.68719,469 shs361,760 shs10 Best Stocks to Own: Fall 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformancePHRPhreesia0.00%-0.36%-8.44%-12.62%+6.62%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumePHRPhreesia$22.23-2.3%$26.10$17.07▼$32.76$1.34B0.68719,469 shs361,760 shs10 Best Stocks to Own: Fall 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformancePHRPhreesia0.00%-0.36%-8.44%-12.62%+6.62%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PricePHRPhreesia 2.93Moderate Buy$33.8552.25% UpsideCurrent Analyst Ratings BreakdownLatest PHR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/8/2025PHRPhreesiaKeyCorpSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOverweight$35.00 ➝ $32.0010/8/2025PHRPhreesiaWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)9/27/2025PHRPhreesiaWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)9/8/2025PHRPhreesiaCitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform9/8/2025PHRPhreesiaDA DavidsonSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy9/8/2025PHRPhreesiaJMP SecuritiesSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetMarket Outperform$30.00 ➝ $34.009/5/2025PHRPhreesiaTruist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$35.00 ➝ $36.009/5/2025PHRPhreesiaRaymond James FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetOutperform$33.009/5/2025PHRPhreesiaCanaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$34.00 ➝ $38.009/5/2025PHRPhreesiaNeedham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$29.00 ➝ $35.00(Data available from 10/19/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookPHRPhreesia$419.81M3.17N/AN/A$4.56 per share4.88Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DatePHRPhreesia-$58.53M-$0.42N/AN/AN/A-5.35%-8.75%-6.12%12/8/2025 (Estimated)Latest PHR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails9/4/2025Q2 2026PHRPhreesia-$0.07$0.01+$0.08$0.01$116.39 million$117.26 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthPHRPhreesiaN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioPHRPhreesia0.022.122.12Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipPHRPhreesia92.10%Insider OwnershipCompanyInsider OwnershipPHRPhreesia5.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionablePHRPhreesia2,08259.91 million56.62 millionOptionablePHR HeadlinesRecent News About These CompaniesPhreesia, Inc. (NYSE:PHR) Given Consensus Rating of "Moderate Buy" by BrokeragesOctober 18 at 2:25 AM | americanbankingnews.comPhreesia, Inc. (NYSE:PHR) Given Consensus Recommendation of "Moderate Buy" by BrokeragesOctober 18 at 2:23 AM | marketbeat.comPhreesia (NYSE:PHR) Earns Sell (D-) Rating from Weiss RatingsOctober 10, 2025 | marketbeat.comKeybanc Maintains Phreesia (PHR) Overweight RecommendationOctober 9, 2025 | msn.comPhreesia Named to the 2025 Capterra Shortlists for Appointment Reminders and Appointment SchedulingOctober 8, 2025 | businesswire.comPhreesia (NYSE:PHR) Stock Price Down 5.2% - Should You Sell?October 1, 2025 | marketbeat.comPhreesia Named to TIME’s 2025 List of the World’s Top HealthTech CompaniesOctober 1, 2025 | finance.yahoo.comPhreesia Named to TIME's 2025 List of the World's Top HealthTech CompaniesSeptember 30, 2025 | businesswire.comAnalysts Offer Insights on Healthcare Companies: Phreesia (PHR) and Novan (NOVN)September 26, 2025 | theglobeandmail.comRiverbridge Partners LLC Cuts Holdings in Phreesia, Inc. $PHRSeptember 25, 2025 | marketbeat.com10,600 Shares in Phreesia, Inc. $PHR Bought by Strs OhioSeptember 25, 2025 | marketbeat.comPhreesia, Inc. (NYSE:PHR) Given Consensus Recommendation of "Buy" by AnalystsSeptember 23, 2025 | marketbeat.comMoody National Bank Trust Division Has $3.28 Million Stock Position in Phreesia, Inc. $PHRSeptember 20, 2025 | marketbeat.comPhreesia, Inc. $PHR Shares Sold by Voya Investment Management LLCSeptember 20, 2025 | marketbeat.comPhreesia (NYSE:PHR) Insider Yvonne Hui Sells 940 SharesSeptember 19, 2025 | marketbeat.comDavid Linetsky Sells 1,064 Shares of Phreesia (NYSE:PHR) StockSeptember 19, 2025 | marketbeat.comInsider Selling: Phreesia (NYSE:PHR) SVP Sells $41,019.36 in StockSeptember 19, 2025 | marketbeat.comAllison Hoffman Sells 2,059 Shares of Phreesia (NYSE:PHR) StockSeptember 19, 2025 | marketbeat.comPhreesia (NYSE:PHR) Insider Sells $50,401.20 in StockSeptember 19, 2025 | marketbeat.comPhreesia (NYSE:PHR) General Counsel Sells $72,936.24 in StockSeptember 19, 2025 | marketbeat.comEvan Roberts Sells 3,761 Shares of Phreesia (NYSE:PHR) StockSeptember 19, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimePHR Company DescriptionsPhreesia NYSE:PHR$22.23 -0.52 (-2.29%) Closing price 10/17/2025 03:59 PM EasternExtended Trading$22.29 +0.06 (+0.27%) As of 10/17/2025 06:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Broadcom Inks OpenAI Deal: Why It's A Huge Win for AVGO Stock Institutions Are Fueling CrowdStrike’s Next Leg Higher This AI Chip Giant Could Be the Market’s Next Big Winner JPMorgan Crushes Q3; But Is the Steady Eddy Stock Hitting A Wall? Microsoft & NVIDIA Unveil GB300 Supercomputer as AI Race Heats Up This Less-Hyped Tech Stock Could Be the Key to the Next AI Wave Archer Buys Rival's Patent Treasure Trove in Strategic Move Prologis Stock Surges: Why the Rally May Continue Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
